explore -WSS

explore

author：hotspot 2025-09-02 08:09:03 - browse：829

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： First Opinion Podcast: How to protect health care in times of war

Wikipedia

WSS

WHO may add ‘noma' to its list of neglected tropical diseases

Does Medicare's free annual wellness visit do any good?

FDA has safety concerns on CRISPR

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Parkland mass shooting to be reenacted for lawsuit

leisure time

explore

Wikipedia

Apple is now the first public company to be valued at $3 trillion

The FDA weighs the risks of candy

Malaria cases in Florida and Texas: Here’s what you need to know

Eli Lilly to pay $200M for Beam’s stake in gene

Medicare proposal to cover medical devices draws a mixed reaction

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Cassava reveals details — and problems — with Alzheimer's study

Virginia high school admissions case could be legal follow

Physician subsidies by hospitals soar in wake of No Surprises Act

hotspot

CDC recommends rationing of RSV shot due to shortages

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Readout Newsletter: XBI biotech index, Akero Therapeutics

Diversifying clinical trials isn't enough to close racial gaps: study

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Why Sanofi got shellacked over its spinoff

hotspot

Wikipedia

Wikipedia

hotspot